ArticleACR open rheumatology2026
Lupus, a Leading Cause of Years of Potential Life Lost in Young Women: Implications for Public Health Priorities and Research Funding.
Article in ACR open rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePremature mortality burden is an important component of disease burden and can help guide health care and research priorities. However, relying solely on mortality rates may underestimate lupus mortality burden because a substantial proportion of deaths occur at younger ages. Years of potential life lost (YPLL) captures premature mortality by applying a predefined age threshold. We estimated the YPLL from lupus in US women relative to leading causes of death and other autoimmune diseases.
methodsUsing the US population-based national Multiple Cause-of-Death database, we obtained death counts for 28 diseases, including lupus, the Centers for Disease Control and Prevention's 15 leading causes of death, and 12 additional autoimmune diseases. We calculated YPLL before age 75 years by summing 75 minus age at death for deaths occurring before age 75. Official cause-of-death rankings were obtained from the Web-based Injury Statistics Query and Reporting System (WISQARS). Sensitivity analyses were repeated in female decedents during 2018 to 2024.
resultsFrom 2000 to 2015, 304.2 thousand years were lost to lupus in US women aged 15 to 44 years. Lupus-associated YPLL ranked 14th in women aged 15 to 44 years and 9th in women aged 15 to 24, exceeding diabetes mellitus, HIV disease, septicemia, chronic lower respiratory disease, anemias, nephritis, and cerebrovascular disease. Among autoimmune diseases, lupus YPLL ranked first in women aged 15 to 24 years and second in women aged 15 to 44 years.
conclusionLupus is a major contributor to premature mortality in young women. Quantifying premature mortality burden through YPLL provides a complementary public health perspective and may inform prioritization of research and public health initiatives.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.